Tags

Type your tag names separated by a space and hit enter

The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008.
Parasitology. 2009 Nov; 136(13):1719-30.P

Abstract

Schistosomiasis remains one of the most prevalent parasitic diseases in developing countries. After malaria, schistosomiasis is the most important tropical disease in terms of human morbidity with significant economic and public health consequences. Although schistosomiasis has recently attracted increased focus and funding for control, it has been estimated that less than 20% of the funding needed to control the disease in Africa is currently available. In this article the following issues are discussed: the rationale, development and objectives of the Schistosomiasis Control Initiative (SCI)-supported programmes; the management approaches followed to achieve implementation by each country; mapping, monitoring and evaluation activities with quantifiable impact of control programmes; monitoring for any potential drug resistance; and finally exit strategies within each country. The results have demonstrated that morbidity due to schistosomiasis has been reduced by the control programmes. While challenges remain, the case for the control of schistosomiasis has been strengthened by research by SCI teams and the principle that a national programme using 'preventive chemotherapy' can be successfully implemented in sub-Saharan Africa, whenever the resources are available. SCI and partners are now actively striving to raise further funds to expand the coverage of integrated control of neglected tropical diseases (NTDs) in sub-Saharan Africa.

Authors+Show Affiliations

Schistosomiasis Control Initiative, Department of Infectious Disease Epidemiology, Imperial College, St. Mary's Campus, Norfolk Place, London W2 1PG, UK. a.fenwick@imperial.ac.ukNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19631008

Citation

Fenwick, A, et al. "The Schistosomiasis Control Initiative (SCI): Rationale, Development and Implementation From 2002-2008." Parasitology, vol. 136, no. 13, 2009, pp. 1719-30.
Fenwick A, Webster JP, Bosque-Oliva E, et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology. 2009;136(13):1719-30.
Fenwick, A., Webster, J. P., Bosque-Oliva, E., Blair, L., Fleming, F. M., Zhang, Y., Garba, A., Stothard, J. R., Gabrielli, A. F., Clements, A. C., Kabatereine, N. B., Toure, S., Dembele, R., Nyandindi, U., Mwansa, J., & Koukounari, A. (2009). The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology, 136(13), 1719-30. https://doi.org/10.1017/S0031182009990400
Fenwick A, et al. The Schistosomiasis Control Initiative (SCI): Rationale, Development and Implementation From 2002-2008. Parasitology. 2009;136(13):1719-30. PubMed PMID: 19631008.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. AU - Fenwick,A, AU - Webster,J P, AU - Bosque-Oliva,E, AU - Blair,L, AU - Fleming,F M, AU - Zhang,Y, AU - Garba,A, AU - Stothard,J R, AU - Gabrielli,A F, AU - Clements,A C A, AU - Kabatereine,N B, AU - Toure,S, AU - Dembele,R, AU - Nyandindi,U, AU - Mwansa,J, AU - Koukounari,A, Y1 - 2009/07/27/ PY - 2009/7/28/entrez PY - 2009/7/28/pubmed PY - 2010/2/6/medline SP - 1719 EP - 30 JF - Parasitology JO - Parasitology VL - 136 IS - 13 N2 - Schistosomiasis remains one of the most prevalent parasitic diseases in developing countries. After malaria, schistosomiasis is the most important tropical disease in terms of human morbidity with significant economic and public health consequences. Although schistosomiasis has recently attracted increased focus and funding for control, it has been estimated that less than 20% of the funding needed to control the disease in Africa is currently available. In this article the following issues are discussed: the rationale, development and objectives of the Schistosomiasis Control Initiative (SCI)-supported programmes; the management approaches followed to achieve implementation by each country; mapping, monitoring and evaluation activities with quantifiable impact of control programmes; monitoring for any potential drug resistance; and finally exit strategies within each country. The results have demonstrated that morbidity due to schistosomiasis has been reduced by the control programmes. While challenges remain, the case for the control of schistosomiasis has been strengthened by research by SCI teams and the principle that a national programme using 'preventive chemotherapy' can be successfully implemented in sub-Saharan Africa, whenever the resources are available. SCI and partners are now actively striving to raise further funds to expand the coverage of integrated control of neglected tropical diseases (NTDs) in sub-Saharan Africa. SN - 1469-8161 UR - https://www.unboundmedicine.com/medline/citation/19631008/The_Schistosomiasis_Control_Initiative__SCI_:_rationale_development_and_implementation_from_2002_2008_ L2 - https://www.cambridge.org/core/product/identifier/S0031182009990400/type/journal_article DB - PRIME DP - Unbound Medicine ER -